Earnings Call · Q2 FY2026·2026-08-10

Q2 26EPS -42.86%·Rev n/aQ1 26EPS -100.00%*·Rev n/aQ4 25EPS +15.79%·Rev n/aQ3 25EPS +21.74%·Rev n/a⚠ consensus missing

Hims & Hers Health, Inc. HIMS

Bill Newby — Director of Investor Relations

Andrew Dudum — Co-Founder & Chief Executive Officer

Mo ElShenawy — Chief Technology Officer

Yemi Okupe — Chief Financial Officer

−4.0%1d on move date3d−9.4%5d−9.9%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more HIMS calls or request research access.

More HIMS calls Browse calls Request research access